There are 749 resources available
Future development for the use of biomarkers
Presenter: Ross Soo
Session: ESMO Colloquium supported by Lilly Oncology: Biomarker-driven treatment decision in metastatic NSCLC
Resources:
Slides
Webcast
Introduction
Presenter: Byoung-Gie Kim
Session: AstraZeneca - PARP inhibitors as targeted therapy for personalised medicine
Resources:
Slides
Webcast
PARPi maintenance: A new paradigm in the management of frontline ovarian cancer
Presenter: Shaheenah Dawood
Session: AstraZeneca - PARP inhibitors as targeted therapy for personalised medicine
Resources:
Slides
Webcast
What’s new in metastatic pancreatic cancer management?
Presenter: Talia Golan
Session: AstraZeneca - PARP inhibitors as targeted therapy for personalised medicine
Resources:
Slides
Webcast
Recent advances in metastatic prostate cancer management
Presenter: Shahneen Sandhu
Session: AstraZeneca - PARP inhibitors as targeted therapy for personalised medicine
Resources:
Slides
Webcast
Expert Opinion on ‘PARP inhibitors as targeted therapy for personalized medicine’ - Panel Discussion
Presenter: John Chia
Session: AstraZeneca - PARP inhibitors as targeted therapy for personalised medicine
Resources:
Slides
Webcast
High incidence and mortality of transitional cell carcinoma in Thai kidney transplant patients
Presenter: Suthanit Laowalert
Session: Mini Oral session - Genitourinary tumours
Resources:
Slides
Webcast
HER2-positive breast cancer: Escalation and de-escalation strategies in the neo/adjuvant setting, who and when
Presenter: Alexandru Eniu
Session: Integrating new treatment paradigms in breast cancer care in 2019
Resources:
Slides
Webcast
HR-positive advanced breast cancer: CDK4 inhibitors, who and when
Presenter: Shom Goel
Session: Integrating new treatment paradigms in breast cancer care in 2019
Resources:
Slides
Webcast
Clinical applications of circulating tumour DNA in advanced setting
Presenter: Fortunato Ciardiello
Session: Precision medicine in advanced gastrointestinal cancer
Resources:
Slides
Webcast